Results 231 to 240 of about 30,886 (249)

Frontotemporal lobar degeneration targets brain regions linked to expression of recently evolved genes. [PDF]

Brain
Pasquini L, Pereira FL, Seddighi S, Zeng Y, Wei Y, Illán-Gala I, Vatsavayai SC, Friedberg A, Lee AJ, Brown JA, Spina S, Grinberg LT, Sirkis DW, Bonham LW, Yokoyama JS, Boxer AL, Kramer JH, Rosen HJ, Humphrey J, Gitler AD, Miller BL, Pollard KS, Ward ME, Seeley WW.   +23 more
europepmc   +1 more source

Increased frontocortical microvascular raspberry density in frontotemporal lobar degeneration compared to Lewy body disease and control cases: a neuropathological study. [PDF]

Free Neuropathol
Olofsson HE, Englund E.
europepmc   +1 more source

Mechanisms behind elevated serum levels of plasminogen activator inhibitor-1 in frontotemporal lobar degeneration. [PDF]

Neural Regen Res
Angelucci F, Hort J.
europepmc   +1 more source

Plasminogen activator inhibitor-1 serum levels in frontotemporal lobar degeneration. [PDF]

J Cell Mol Med
Angelucci F, Veverova K, Katonová A, Vyhnalek M, Hort J.   +4 more
europepmc   +1 more source

Frontotemporal lobar degeneration changes neuronal beta-frequency dynamics during the mismatch negativity response. [PDF]

Neuroimage Clin
Perry A, Hughes LE, Adams NE, Naessens M, Kloosterman NA, Rouse MA, Murley AG, Street D, Jones PS, Rowe JB.   +9 more
europepmc   +1 more source

Plasma biomarkers increase diagnostic confidence in patients with Alzheimer's disease or frontotemporal lobar degeneration. [PDF]

Alzheimers Res Ther
Altomare D, Libri I, Alberici A, Rivolta J, Padovani A, Ashton NJ, Zetterberg H, Blennow K, Borroni B.   +8 more
europepmc   +1 more source